BMC Research Notes (Jun 2018)

Identification of cyclic hexapeptides natural products with inhibitory potency against Mycobacterium tuberculosis

  • Sheo B. Singh,
  • Joshua Odingo,
  • Mai A. Bailey,
  • Bjorn Sunde,
  • Aaron Korkegian,
  • Theresa O’Malley,
  • Yulia Ovechkina,
  • Thomas R. Ioerger,
  • James C. Sacchettini,
  • Katherine Young,
  • David B. Olsen,
  • Tanya Parish

DOI
https://doi.org/10.1186/s13104-018-3526-z
Journal volume & issue
Vol. 11, no. 1
pp. 1 – 5

Abstract

Read online

Abstract Objective Our aim was to identify natural products with anti-tubercular activity. Results A set of ~ 500 purified natural product compounds was screened for inhibition against the human pathogen Mycobacterium tuberculosis. A series of cyclic hexapeptides with anti-tubercular activity was identified. Five analogs from a set of sixteen closely related compounds were active, with minimum inhibitory concentrations ranging from 2.3 to 8.9 μM. Eleven structural analogs had no significant activity (MIC > 20 μM) demonstrating structure activity relationship. Sequencing of resistant mutant isolates failed to identify changes accounting for the resistance phenotype.

Keywords